Moderna
MRNA
#1157
Rank
S$25.59 B
Marketcap
S$64.53
Share price
-0.55%
Change (1 day)
82.98%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -S$3.59 Billion

According to Moderna 's latest financial reports the company's current earnings are S$1.92 Billion. , an increase over its 2024 earnings that were of -S$4.57 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -S$3.52 Billion-23.03%
2024 -S$4.57 Billion-8.22%
2023 -S$4.98 Billion-140.65%
2022 S$12.22 B-27.81%
2021 S$16.93 B-1911.15%
2020 -S$0.94 Billion44.7%
2019 -S$0.65 Billion28.63%
2018 -S$0.51 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$42.72 B-1,316.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.82 B-692.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
S$28.55 B-913.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-S$60.4 Million-98.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.15 Billion-95.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-S$53.18 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$0.73 B-120.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
S$0.43 B-112.51%๐Ÿ‡บ๐Ÿ‡ธ USA